Arca
Skip to content
Tools
Tools

Allyx Therapeutics, Inc.

4 private offerings reported to the SEC on Form D since 2016, $41.1M sold in all. Biotech, Connecticut.

  • Form D offerings: 4
  • Reported sold: $41.1M
  • Newest: May 11, 2026
  • FDA records: Company page

Every Form D offering

Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
May 11, 2026—$27.9M$30.0MAllyx Therapeutics, Inc.Biotech · ConnecticutOct 21, 20260001865257-26-000004
Mar 3, 2026—$3.3M$4.0MAllyx Therapeutics, Inc.Biotech · ConnecticutNot amended0001865257-26-000003
Feb 10, 2023—$2.3M$2.3MAllyx Therapeutics, Inc.Biotech · ConnecticutNot amended0001865257-23-000001
Jun 2, 2021—$7.6M$8.0MAllyx Therapeutics, Inc.Biotech · ConnecticutNot amended0001865257-21-000001

SEC Profile

From the company's EDGAR record
Business address
New Haven, CT
Incorporated in
Delaware
All SEC filings
CIK 1865257 on EDGAR

A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.